UBS Group raised its price target for C3.ai (NYSE:AI) to $16.00.

According to a study conducted and presented Thursday by equity analysts UBS Group, they were shown to have lowered their price target for C3.ai (NYSE:AI) from $19.00 to $16.00. This information was revealed in The Fly. The company currently advises investors to “hold” their shares in the company. According to the price target provided by the UBS Group, the company’s price is likely to decline by 11.11% from its current level. C3: It is prudent for companies to invest in research and development of artificial intelligence. Other industry experts have also been disseminating the findings of their research on the company, which they have conducted on it. In a research note published on June 2, JMP Securities lowered its “market outperformance” rating and price target for C3.ai, which was previously $59.00. The new price target is $28.00. On Friday, June 3, Bloomberg categorized C3.ai as a “sell,” which is a change from its previous recommendation of “hold.” On Tuesday August 16, Wolfe Research published a report in which they talked about C3.ai for the first time. They gave the stock a “market performance” rating for its performance. Needham & Company LLC lowered its price target on C3.ai from $26.00 to $20.00 and gave the company a “buy” rating in a report released Thursday, June 2.

In a research note released Thursday, Piper Sandler lowered her target price for C3.ai from $18.00 to $14.00 and listed the company as “neutral.” This brings us to our last point. Four analysts advise clients to sell their stocks, seven advise clients to hold their current holdings and two advise clients to buy their stocks. According to information made available by Bloomberg, the recommendation for C3.ai stock is to “hold”, and the average price target set is $19.25. Thursday was the first day of the NYSE: the AI ​​was available for trading and the opening price was $18.00. In the previous year, the cost of C3.ai varied from $13.37 to $55.58 several times. The company has a price-earnings ratio of -9.68 and a beta value of 0.49, and its market capitalization is equal to $1.93 billion. The stock price has had a moving average of $19.65 over the past 200 days; in the last 50 days the price has been $19.74. The current stock price of C3.AI is growing dangerously close to a price at which it would be wise to buy. On August 31, the latest quarterly earnings report from C3.ai, which trades on the NYSE under the symbol AI, was released. The company reported a loss of $0.12 per share for the quarter, $0.12 better than the consensus estimate of $0.24 per share. C3.ai had a negative net margin and a negative return on equity for the business. The negative net margin was 75.09% and the negative return on equity was -144.11%. By comparison, quarterly sales came in at $65.31 million, which is below the typical anticipation of $66.02 million set by market analysts.

During the same period a year earlier, the company lost $0.23 per share. Revenues generated during this quarter increased by 24.6% compared to the same period last year. Industry analyst forecasts indicate that C3.ai will likely end the current fiscal year with a loss of 2.1 cents per share. On August 1, 2,120 C3.ai shares were sold by Juho Parkkinen, the company’s chief financial officer. Parkkinen is responsible for the company’s finances. The price per share averaged $18.19 and a total of $38,562.80 worth of shares was sold. The company’s CFO now owns a total of 363,926 shares of the company, which are worth $6,619,813.94 as of today. Follow the link, which will take you to a filing filed with the Securities and Exchange Commission. You will have the opportunity to acquire additional information regarding the transaction. Company insiders sold 4,390 shares of the company in the past three months, bringing in a total of $79,912. There is a stake in the company held by insiders of the company, equal to 38.08% of all shares. The number of company shares held by hedge funds and other institutional investors has increased due to recent purchases. Point72 Hong Kong Ltd. made a financial investment of $25,000 in C3.ai during the second quarter of the year. $31,000 was donated to C3.ai by Ahrens Investment Partners LLC during the second quarter of the year. In the first three months of 2018, the Canada Pension Plan Investment Board increased its holdings of C3.ai shares by 755.8%.

After making an additional purchase of 1,300 shares in the last quarter, the Canada Pension Plan Investment Board now owns 1,472 shares of the company, or $34,000. These shares were acquired as a result of the investment decision of the Canada Pension Plan Investment Board. In the first three months of 2018, Benjamin Edwards Inc. added approximately $40,000 to its C3.ai holdings. Last but not least, during the first quarter of 2018, approximately $44,000 was spent by MetLife Position Management LLC to acquire a new position in C3.ai. Institutional investors and hedge funds collectively own 44.34% of the total number of shares in the company, constituting the majority of these shareholders. C3.ai, Inc. is a company specializing in the development of artificial intelligence (AI) software for commercial use. The company provides several different services to other companies related to software as a service. Its software offerings include C3 AI Applications, which provides turnkey AI solutions for various industries and applications, and C3 AI Suite, a platform-as-a-service application development and runtime environment that enables users to design, develop and deploy enterprise AI applications. . Both of these offerings are included in the company’s software portfolio. On the company’s website, you can find information regarding both options.

Eleanor C. William